 | • レポートコード：MRC2102QY15551 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のチロシンキナーゼJAK阻害剤市場について種類別（トファシチニブ、ルキソリチニブ、バリシチニブ）、用途別（関節リウマチ（RA）、真性多血症（PCV）、骨髄線維症（MF）、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・チロシンキナーゼJAK阻害剤市場の概要 ・世界の主要地域別チロシンキナーゼJAK阻害剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のチロシンキナーゼJAK阻害剤市場規模2015-2026：種類別（トファシチニブ、ルキソリチニブ、バリシチニブ） ・世界のチロシンキナーゼJAK阻害剤市場規模2015-2026：用途別（関節リウマチ（RA）、真性多血症（PCV）、骨髄線維症（MF）、その他） ・チロシンキナーゼJAK阻害剤の米国市場規模2015-2020 ・チロシンキナーゼJAK阻害剤のヨーロッパ市場規模2015-2020 ・チロシンキナーゼJAK阻害剤の中国市場規模2015-2020 ・チロシンキナーゼJAK阻害剤の日本市場規模2015-2020 ・チロシンキナーゼJAK阻害剤の東南アジア市場規模2015-2020 ・チロシンキナーゼJAK阻害剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・チロシンキナーゼJAK阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・チロシンキナーゼJAK阻害剤の市場動向・機会・課題 ・調査の結論 |
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
These inhibitors have therapeutic application in the treatment of cancer and inflammatory diseases such as rheumatoid arthritis. There is interest in their use for various skin conditions. JAK3 inhibitors are attractive as a possible treatment of various autoimmune diseases since its functions is mainly restricted to lymphocytes. Development for a selective JAK3 inhibitors are ongoing.
In the report, we only count drugs for human beings. And the 1 unit is 1 tablet.
Tyrosine Kinase JAK Inhibitors is widely used in Rheumatoid Arthritis (RA), Polycythemia Vera (PCV) and Myelofibrosis (MF). The most proportion of Tyrosine Kinase JAK Inhibitors is for Rheumatoid Arthritis (RA), and the proportion in 2017 is about 37%.
Market Analysis and Insights: Global Tyrosine Kinase JAK Inhibitors Market
The global Tyrosine Kinase JAK Inhibitors market size is projected to reach US$ 320630 million by 2026, from US$ 18060 million in 2020, at a CAGR of 61.5% during 2021-2026.
Global Tyrosine Kinase JAK Inhibitors Scope and Market Size
The global Tyrosine Kinase JAK Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tyrosine Kinase JAK Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Tyrosine Kinase JAK Inhibitors market is segmented into
Tofacitinib
Ruxolitinib
Baricitinib
Segment by Application, the Tyrosine Kinase JAK Inhibitors market is segmented into
Rheumatoid Arthritis (RA)
Polycythemia Vera (PCV)
Myelofibrosis (MF)
Others
The Tyrosine Kinase JAK Inhibitors market is analysed and market size information is provided by regions (countries). Segment by Application, the Tyrosine Kinase JAK Inhibitors market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tyrosine Kinase JAK Inhibitors Market Share Analysis
Tyrosine Kinase JAK Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tyrosine Kinase JAK Inhibitors business, the date to enter into the Tyrosine Kinase JAK Inhibitors market, Tyrosine Kinase JAK Inhibitors product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Incyte
Novartis
Eli Lilly
Gilead
Sanofi
Galapagos
AbbVie
Vertex
Teva
Astellas Pharma
Celgene
CTI BioPharma
1 Tyrosine Kinase JAK Inhibitors Market Overview
1.1 Tyrosine Kinase JAK Inhibitors Product Scope
1.2 Tyrosine Kinase JAK Inhibitors Segment by Type
1.2.1 Global Tyrosine Kinase JAK Inhibitors Sales by Type (2020-2026)
1.2.2 Tofacitinib
1.2.3 Ruxolitinib
1.2.4 Baricitinib
1.3 Tyrosine Kinase JAK Inhibitors Segment by Application
1.3.1 Global Tyrosine Kinase JAK Inhibitors Sales Comparison by Application (2020-2026)
1.3.2 Rheumatoid Arthritis (RA)
1.3.3 Polycythemia Vera (PCV)
1.3.4 Myelofibrosis (MF)
1.3.5 Others
1.4 Tyrosine Kinase JAK Inhibitors Market Estimates and Forecasts (2015-2026)
1.4.1 Global Tyrosine Kinase JAK Inhibitors Sales Growth Rate (2015-2026)
1.4.2 Global Tyrosine Kinase JAK Inhibitors Revenue and Growth Rate (2015-2026)
1.4.3 Global Tyrosine Kinase JAK Inhibitors Price Trends (2015-2026)
2 Tyrosine Kinase JAK Inhibitors Estimate and Forecast by Region
2.1 Global Tyrosine Kinase JAK Inhibitors Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Tyrosine Kinase JAK Inhibitors Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Region (2015-2020)
2.2.2 Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Region (2015-2020)
2.3 Global Tyrosine Kinase JAK Inhibitors Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Tyrosine Kinase JAK Inhibitors Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Tyrosine Kinase JAK Inhibitors Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Tyrosine Kinase JAK Inhibitors Estimates and Projections (2015-2026)
2.4.2 Europe Tyrosine Kinase JAK Inhibitors Estimates and Projections (2015-2026)
2.4.3 China Tyrosine Kinase JAK Inhibitors Estimates and Projections (2015-2026)
2.4.4 Japan Tyrosine Kinase JAK Inhibitors Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Tyrosine Kinase JAK Inhibitors Estimates and Projections (2015-2026)
2.4.6 India Tyrosine Kinase JAK Inhibitors Estimates and Projections (2015-2026)
3 Global Tyrosine Kinase JAK Inhibitors Competition Landscape by Players
3.1 Global Top Tyrosine Kinase JAK Inhibitors Players by Sales (2015-2020)
3.2 Global Top Tyrosine Kinase JAK Inhibitors Players by Revenue (2015-2020)
3.3 Global Tyrosine Kinase JAK Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tyrosine Kinase JAK Inhibitors as of 2019)
3.4 Global Tyrosine Kinase JAK Inhibitors Average Price by Company (2015-2020)
3.5 Manufacturers Tyrosine Kinase JAK Inhibitors Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Tyrosine Kinase JAK Inhibitors Players (Opinion Leaders)
4 Global Tyrosine Kinase JAK Inhibitors Market Size by Type
4.1 Global Tyrosine Kinase JAK Inhibitors Historic Market Review by Type (2015-2020)
4.1.1 Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
4.1.2 Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Type (2015-2020)
4.1.3 Global Tyrosine Kinase JAK Inhibitors Price by Type (2015-2020)
4.2 Global Tyrosine Kinase JAK Inhibitors Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Tyrosine Kinase JAK Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Tyrosine Kinase JAK Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Global Tyrosine Kinase JAK Inhibitors Price Forecast by Type (2021-2026)
5 Global Tyrosine Kinase JAK Inhibitors Market Size by Application
5.1 Global Tyrosine Kinase JAK Inhibitors Historic Market Review by Application (2015-2020)
5.1.1 Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
5.1.2 Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Application (2015-2020)
5.1.3 Global Tyrosine Kinase JAK Inhibitors Price by Application (2015-2020)
5.2 Global Tyrosine Kinase JAK Inhibitors Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Tyrosine Kinase JAK Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Tyrosine Kinase JAK Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Tyrosine Kinase JAK Inhibitors Price Forecast by Application (2021-2026)
6 United States Tyrosine Kinase JAK Inhibitors Market Facts & Figures
6.1 United States Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2015-2020)
6.2 United States Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
6.3 United States Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
7 Europe Tyrosine Kinase JAK Inhibitors Market Facts & Figures
7.1 Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2015-2020)
7.2 Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
7.3 Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
8 China Tyrosine Kinase JAK Inhibitors Market Facts & Figures
8.1 China Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2015-2020)
8.2 China Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
8.3 China Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
9 Japan Tyrosine Kinase JAK Inhibitors Market Facts & Figures
9.1 Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (3015-3030)
9.2 Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
9.3 Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
10 Southeast Asia Tyrosine Kinase JAK Inhibitors Market Facts & Figures
10.1 Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
11 India Tyrosine Kinase JAK Inhibitors Market Facts & Figures
11.1 India Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2015-2020)
11.2 India Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
11.3 India Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Tyrosine Kinase JAK Inhibitors Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Tyrosine Kinase JAK Inhibitors Products Offered
12.1.5 Pfizer Recent Development
12.2 Incyte
12.2.1 Incyte Corporation Information
12.2.2 Incyte Business Overview
12.2.3 Incyte Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Incyte Tyrosine Kinase JAK Inhibitors Products Offered
12.2.5 Incyte Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Tyrosine Kinase JAK Inhibitors Products Offered
12.3.5 Novartis Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Corporation Information
12.4.2 Eli Lilly Business Overview
12.4.3 Eli Lilly Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Lilly Tyrosine Kinase JAK Inhibitors Products Offered
12.4.5 Eli Lilly Recent Development
12.5 Gilead
12.5.1 Gilead Corporation Information
12.5.2 Gilead Business Overview
12.5.3 Gilead Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Gilead Tyrosine Kinase JAK Inhibitors Products Offered
12.5.5 Gilead Recent Development
12.6 Sanofi
12.6.1 Sanofi Corporation Information
12.6.2 Sanofi Business Overview
12.6.3 Sanofi Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanofi Tyrosine Kinase JAK Inhibitors Products Offered
12.6.5 Sanofi Recent Development
12.7 Galapagos
12.7.1 Galapagos Corporation Information
12.7.2 Galapagos Business Overview
12.7.3 Galapagos Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Galapagos Tyrosine Kinase JAK Inhibitors Products Offered
12.7.5 Galapagos Recent Development
12.8 AbbVie
12.8.1 AbbVie Corporation Information
12.8.2 AbbVie Business Overview
12.8.3 AbbVie Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.8.4 AbbVie Tyrosine Kinase JAK Inhibitors Products Offered
12.8.5 AbbVie Recent Development
12.9 Vertex
12.9.1 Vertex Corporation Information
12.9.2 Vertex Business Overview
12.9.3 Vertex Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Vertex Tyrosine Kinase JAK Inhibitors Products Offered
12.9.5 Vertex Recent Development
12.10 Teva
12.10.1 Teva Corporation Information
12.10.2 Teva Business Overview
12.10.3 Teva Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Teva Tyrosine Kinase JAK Inhibitors Products Offered
12.10.5 Teva Recent Development
12.11 Astellas Pharma
12.11.1 Astellas Pharma Corporation Information
12.11.2 Astellas Pharma Business Overview
12.11.3 Astellas Pharma Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Astellas Pharma Tyrosine Kinase JAK Inhibitors Products Offered
12.11.5 Astellas Pharma Recent Development
12.12 Celgene
12.12.1 Celgene Corporation Information
12.12.2 Celgene Business Overview
12.12.3 Celgene Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Celgene Tyrosine Kinase JAK Inhibitors Products Offered
12.12.5 Celgene Recent Development
12.13 CTI BioPharma
12.13.1 CTI BioPharma Corporation Information
12.13.2 CTI BioPharma Business Overview
12.13.3 CTI BioPharma Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.13.4 CTI BioPharma Tyrosine Kinase JAK Inhibitors Products Offered
12.13.5 CTI BioPharma Recent Development
13 Tyrosine Kinase JAK Inhibitors Manufacturing Cost Analysis
13.1 Tyrosine Kinase JAK Inhibitors Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Tyrosine Kinase JAK Inhibitors
13.4 Tyrosine Kinase JAK Inhibitors Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Tyrosine Kinase JAK Inhibitors Distributors List
14.3 Tyrosine Kinase JAK Inhibitors Customers
15 Market Dynamics
15.1 Tyrosine Kinase JAK Inhibitors Market Trends
15.2 Tyrosine Kinase JAK Inhibitors Opportunities and Drivers
15.3 Tyrosine Kinase JAK Inhibitors Market Challenges
15.4 Tyrosine Kinase JAK Inhibitors Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Tyrosine Kinase JAK Inhibitors Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) by Region (2015-2020)
Table 5. Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Region (2015-2020)
Table 6. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Region (2015-2020)
Table 8. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Tyrosine Kinase JAK Inhibitors Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Tyrosine Kinase JAK Inhibitors Revenue Share Forecast by Region (2021-2026)
Table 12. Global Tyrosine Kinase JAK Inhibitors (K Units) of Key Companies (2015-2020)
Table 13. Global Tyrosine Kinase JAK Inhibitors Sales Share by Company (2015-2020)
Table 14. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Company (2015-2020)
Table 16. Global Tyrosine Kinase JAK Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tyrosine Kinase JAK Inhibitors as of 2019)
Table 17. Global Tyrosine Kinase JAK Inhibitors Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Tyrosine Kinase JAK Inhibitors Manufacturing Sites and Area Served
Table 19. Manufacturers Tyrosine Kinase JAK Inhibitors Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Tyrosine Kinase JAK Inhibitors Players
Table 22. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) by Type (2015-2020)
Table 23. Global Tyrosine Kinase JAK Inhibitors Sales Share by Type (2015-2020)
Table 24. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Tyrosine Kinase JAK Inhibitors Price (K Units) by Type (2015-2020)
Table 26. Global Tyrosine Kinase JAK Inhibitors Sales Share by Type (2021-2026)
Table 27. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Type (2021-2026)
Table 29. Global Tyrosine Kinase JAK Inhibitors Price (K Units) by Type (2021-2026)
Table 30. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) by Application (2015-2020)
Table 31. Global Tyrosine Kinase JAK Inhibitors Sales Share by Application (2015-2020)
Table 32. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Tyrosine Kinase JAK Inhibitors Price (K Units) by Application (2015-2020)
Table 34. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) by Application (2021-2026)
Table 35. Global Tyrosine Kinase JAK Inhibitors Sales Share by Application (2021-2026)
Table 36. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Application (2021-2026)
Table 38. Global Tyrosine Kinase JAK Inhibitors Price (K Units) by Application (2021-2026)
Table 39. United States Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2015-2020)
Table 40. United States Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2015-2020)
Table 41. United States Tyrosine Kinase JAK Inhibitors Sales (K Units) by Type (2015-2020)
Table 42. United States Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
Table 43. United States Tyrosine Kinase JAK Inhibitors Sales (K Units) by Application (2015-2020)
Table 44. United States Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
Table 45. Europe Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2015-2020)
Table 46. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2015-2020)
Table 47. Europe Tyrosine Kinase JAK Inhibitors Sales (K Units) by Type (2015-2020)
Table 48. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
Table 49. Europe Tyrosine Kinase JAK Inhibitors Sales (K Units) by Application (2015-2020)
Table 50. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
Table 51. China Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2015-2020)
Table 52. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2015-2020)
Table 53. China Tyrosine Kinase JAK Inhibitors Sales (K Units) by Type (2015-2020)
Table 54. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
Table 55. China Tyrosine Kinase JAK Inhibitors Sales (K Units) by Application (2015-2020)
Table 56. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
Table 57. Japan Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2015-2020)
Table 58. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2015-2020)
Table 59. Japan Tyrosine Kinase JAK Inhibitors Sales (K Units) by Type (2015-2020)
Table 60. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
Table 61. Japan Tyrosine Kinase JAK Inhibitors Sales (K Units) by Application (2015-2020)
Table 62. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
Table 69. India Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2015-2020)
Table 70. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2015-2020)
Table 71. India Tyrosine Kinase JAK Inhibitors Sales (K Units) by Type (2015-2020)
Table 72. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2015-2020)
Table 73. India Tyrosine Kinase JAK Inhibitors Sales (K Units) by Application (2015-2020)
Table 74. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Pfizer Tyrosine Kinase JAK Inhibitors Product
Table 79. Pfizer Recent Development
Table 80. Incyte Corporation Information
Table 81. Incyte Description and Business Overview
Table 82. Incyte Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Incyte Tyrosine Kinase JAK Inhibitors Product
Table 84. Incyte Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Novartis Tyrosine Kinase JAK Inhibitors Product
Table 89. Novartis Recent Development
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Eli Lilly Tyrosine Kinase JAK Inhibitors Product
Table 94. Eli Lilly Recent Development
Table 95. Gilead Corporation Information
Table 96. Gilead Description and Business Overview
Table 97. Gilead Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Gilead Tyrosine Kinase JAK Inhibitors Product
Table 99. Gilead Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sanofi Tyrosine Kinase JAK Inhibitors Product
Table 104. Sanofi Recent Development
Table 105. Galapagos Corporation Information
Table 106. Galapagos Description and Business Overview
Table 107. Galapagos Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Galapagos Tyrosine Kinase JAK Inhibitors Product
Table 109. Galapagos Recent Development
Table 110. AbbVie Corporation Information
Table 111. AbbVie Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. AbbVie Description and Business Overview
Table 113. AbbVie Tyrosine Kinase JAK Inhibitors Product
Table 114. AbbVie Recent Development
Table 115. Vertex Corporation Information
Table 116. Vertex Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Vertex Description and Business Overview
Table 118. Vertex Tyrosine Kinase JAK Inhibitors Product
Table 119. Vertex Recent Development
Table 120. Teva Corporation Information
Table 121. Teva Description and Business Overview
Table 122. Teva Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Teva Tyrosine Kinase JAK Inhibitors Product
Table 124. Teva Recent Development
Table 125. Astellas Pharma Corporation Information
Table 126. Astellas Pharma Description and Business Overview
Table 127. Astellas Pharma Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Astellas Pharma Tyrosine Kinase JAK Inhibitors Product
Table 129. Astellas Pharma Recent Development
Table 130. Celgene Corporation Information
Table 131. Celgene Description and Business Overview
Table 132. Celgene Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Celgene Tyrosine Kinase JAK Inhibitors Product
Table 134. Celgene Recent Development
Table 135. CTI BioPharma Corporation Information
Table 136. CTI BioPharma Description and Business Overview
Table 137. CTI BioPharma Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. CTI BioPharma Tyrosine Kinase JAK Inhibitors Product
Table 139. CTI BioPharma Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Tyrosine Kinase JAK Inhibitors Distributors List
Table 143. Tyrosine Kinase JAK Inhibitors Customers List
Table 144. Tyrosine Kinase JAK Inhibitors Market Key Trends
Table 145. Tyrosine Kinase JAK Inhibitors Key Opportunities and Drivers
Table 146. Tyrosine Kinase JAK Inhibitors Market Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Tyrosine Kinase JAK Inhibitors Product Picture
Figure 2. Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Tyrosine Kinase JAK Inhibitors Market Share by Application in 2020 & 2026
Figure 6. Rheumatoid Arthritis (RA) Examples
Figure 7. Polycythemia Vera (PCV) Examples
Figure 8. Myelofibrosis (MF) Examples
Figure 9. Others Examples
Figure 10. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Tyrosine Kinase JAK Inhibitors Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Tyrosine Kinase JAK Inhibitors Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Tyrosine Kinase JAK Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Tyrosine Kinase JAK Inhibitors Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Tyrosine Kinase JAK Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Tyrosine Kinase JAK Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Tyrosine Kinase JAK Inhibitors Players Market Share by Revenue in Tyrosine Kinase JAK Inhibitors 2015 & 2019
Figure 28. Tyrosine Kinase JAK Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Type (2015-2020)
Figure 30. Global Tyrosine Kinase JAK Inhibitors Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Application (2015-2020)
Figure 32. Global Tyrosine Kinase JAK Inhibitors Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2019
Figure 34. United States Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2019
Figure 35. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Company in 2019
Figure 36. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2019
Figure 37. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2019
Figure 38. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Company in 2019
Figure 39. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2019
Figure 40. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2019
Figure 41. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Company in 2019
Figure 42. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2019
Figure 43. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2019
Figure 44. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Company in 2019
Figure 45. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2019
Figure 46. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2019
Figure 47. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Company in 2019
Figure 48. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2019
Figure 49. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Tyrosine Kinase JAK Inhibitors
Figure 52. Manufacturing Process Analysis of Tyrosine Kinase JAK Inhibitors
Figure 53. Tyrosine Kinase JAK Inhibitors Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
非チロシンキナーゼ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Non-Tyrosine Kinase Inhibitors Market The global Non-Tyrosine Kinase Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Non-Tyrosine Kinase Inhibitors Scope and Market Size T…- 受容体チロシンプロテインキナーゼERBB3の世界市場レポート2020 Market Analysis and Insights: Global Receptor Tyrosine Protein Kinase ERBB 3 Market The global Receptor Tyrosine Protein Kinase ERBB 3 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Receptor Tyrosine Protein Kinase ERB…
- プロテインキナーゼ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Protein Kinase Inhibitor Market The global Protein Kinase Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Protein Kinase Inhibitor Scope and Market Size The global Protein …
- 非受容体型チロシンプロテインホスファターゼ1の世界市場レポート2020 Market Analysis and Insights: Global Tyrosine Protein Phosphatase Non Receptor Type 1 Market The global Tyrosine Protein Phosphatase Non Receptor Type 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tyrosine Protein P…
- クレアチンキナーゼの世界市場レポート2020 Creatine kinase was mainly found in skeletal muscle, myocardium and smooth muscle, followed by brain tissue, gastrointestinal tract, lung and kidney. Creatine kinase mainly exists in the cytoplasm and mitochondria, and is an important kinase directly related to the intracellular energy operation, mu…